Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Dyne Therapeutics, Inc. | Director | Common Stock | 5.79M | $190M | $32.82 | Nov 14, 2024 | Indirect |
Dyne Therapeutics, Inc. | Director | Stock option (right to buy) | 25.1K | May 22, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
DYN | Dyne Therapeutics, Inc. | Nov 13, 2024 | 2 | -$674K | 4 | Nov 15, 2024 | Director |
DYN | Dyne Therapeutics, Inc. | Oct 18, 2024 | 2 | -$476K | 4 | Oct 22, 2024 | Director |
DYN | Dyne Therapeutics, Inc. | Oct 16, 2024 | 2 | -$1.29M | 4 | Oct 18, 2024 | Director |
DYN | Dyne Therapeutics, Inc. | Oct 3, 2024 | 1 | -$191K | 4 | Oct 7, 2024 | Director |
DYN | Dyne Therapeutics, Inc. | Oct 1, 2024 | 2 | -$1.06M | 4 | Oct 3, 2024 | Director |
DYN | Dyne Therapeutics, Inc. | Sep 27, 2024 | 3 | -$1.1M | 4 | Oct 1, 2024 | Director |
DYN | Dyne Therapeutics, Inc. | Sep 25, 2024 | 2 | -$127K | 4 | Sep 27, 2024 | Director |
DYN | Dyne Therapeutics, Inc. | Sep 20, 2024 | 4 | -$4.34M | 4 | Sep 24, 2024 | Director |
DYN | Dyne Therapeutics, Inc. | Sep 18, 2024 | 3 | -$2.9M | 4 | Sep 20, 2024 | Director |
DYN | Dyne Therapeutics, Inc. | Sep 16, 2024 | 2 | -$161K | 4 | Sep 18, 2024 | Director |
DYN | Dyne Therapeutics, Inc. | Sep 5, 2024 | 1 | -$55.2K | 4 | Sep 9, 2024 | Director |
DYN | Dyne Therapeutics, Inc. | Aug 30, 2024 | 2 | -$1.43M | 4 | Sep 4, 2024 | Director |
DYN | Dyne Therapeutics, Inc. | Aug 28, 2024 | 4 | -$6.05M | 4 | Aug 30, 2024 | Director |
DYN | Dyne Therapeutics, Inc. | Aug 26, 2024 | 3 | -$6.95M | 4 | Aug 28, 2024 | Director |
DYN | Dyne Therapeutics, Inc. | Aug 22, 2024 | 4 | -$8.3M | 4 | Aug 26, 2024 | Director |
DYN | Dyne Therapeutics, Inc. | Aug 20, 2024 | 5 | -$10.4M | 4 | Aug 22, 2024 | Director |
DYN | Dyne Therapeutics, Inc. | Aug 16, 2024 | 6 | -$11.3M | 4 | Aug 20, 2024 | Director |
DYN | Dyne Therapeutics, Inc. | Aug 14, 2024 | 3 | -$12.6M | 4 | Aug 16, 2024 | Director |
DYN | Dyne Therapeutics, Inc. | Aug 12, 2024 | 5 | -$9.12M | 4 | Aug 14, 2024 | Director |
DYN | Dyne Therapeutics, Inc. | Aug 8, 2024 | 6 | -$7.88M | 4/A | Aug 14, 2024 | Director |
DYN | Dyne Therapeutics, Inc. | Aug 8, 2024 | 6 | -$7.88M | 4 | Aug 12, 2024 | Director |
DYN | Dyne Therapeutics, Inc. | May 22, 2024 | 1 | $0 | 4 | May 24, 2024 | Director |
DYN | Dyne Therapeutics, Inc. | Jan 9, 2024 | 2 | $30M | 4 | Jan 11, 2024 | Director, 10%+ Owner |
DYN | Dyne Therapeutics, Inc. | May 24, 2023 | 1 | $0 | 4 | May 25, 2023 | Director, 10%+ Owner |
DYN | Dyne Therapeutics, Inc. | Jun 3, 2022 | 1 | $0 | 4 | Jun 6, 2022 | Director, 10%+ Owner |
DYN | Dyne Therapeutics, Inc. | May 26, 2021 | 1 | $0 | 4 | May 27, 2021 | Director, 10%+ Owner |